Enhancement of anticancer effects by HSV-TK potentiators and evaluation of navel liposome vectors in MSV-TK/prodding gene therapy
Enhancement of anticancer effects by HSV-TK potentiators and evaluation of navel liposome vectors in MSV-TK/prodding gene therapy
批准号:
12672210
负责人:
HAYASHI Kyoko
金额:
$2.11万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
在癌症基因治疗试验中,单纯疱疹病毒特异性胸苷激酶(单纯疱疹病毒特异性胸苷激酶)已被用作更昔洛韦(GCV)或阿昔洛韦(ACV)存在时的自杀基因。两种二萜,scopadulciol (SDC)和ponicidin (PND)选择性地刺激HSV-TK酶活性。因此,我们研究了这些化合物在表达hsv - tk的癌细胞中增强GCV/ACV毒性。结果如下:1)转染:用含有hsv - ltk基因的质粒转染人癌细胞。克隆后获得稳定表达hsv -TK (TK^+)的细胞克隆。这些转染物在裸鼠体内显示出形成肿瘤的能力。2)体内抗癌作用:与单独给药ACV或GCV相比,SDC/PND与ACV或SDC/PND与GCV联合给药可显著抑制TK^+细胞的体内生长,尽管剂量较低。3)旁观者效应:在体外和体内系统中测定了SDC和PND增强产品旁观者效应的能力。体外联合使用SDC/PND。与前药相比,ACV/GCV使肿瘤细胞仅在1 - 20%的TK^+细胞中对前药更敏感。在给裸鼠注射3%或10% TK^+细胞的体内实验中,与仅用produg治疗的小鼠相比,用药物联合治疗的小鼠肿瘤体积显著减少。4)毒性和功效:即使给药剂量比体内实验高10倍,SDC和PND对小鼠均无毒性。SDC比PND具有更强的作用,并且有可能从植物的器官培养物中稳定供应。5)脂质体载体效率评价:在大豆甾醇苷存在的情况下,阳离子脂质体对基因的转染效率提高。该脂质体也提高了肝脏的靶向性。
英文摘要
In cancer gene therapy trials, herpes simplex virus-specific thymidine kinase (HSV-TK) has been used as a suicide gene in the presence of ganciclovir (GCV) or acyclovir (ACV). Two diterpenoids, scopadulciol (SDC) and ponicidin (PND), stimulated selectively the HSV-TK enzymatic activity. Thus, we studied the potentiation of GCV/ACV toxicity by these compounds in HSV-TK-expressing cancer cells. The results obtained were as follows:1) Transfectants: Human cancer cells were transfected with the plasmid containing HSV-l tk gene. After cloning, stably HSV-TK-expressing (TK^+) cell clones were obtained. These transfectants showed the ability of forming tumors in nude mice.2) In vivo anticancer effects: The in vivo growth of TK^+ cells was significantly inhibited by coadministration of SDC/PND and ACV, or of SDC/PND and GCV, compared with single administration of ACV or GCV in spite of lower doses.3) Bystander effects: The abilities of SDC and PND to potentiate the bystander effects of the products were determined in both in vitro and in vivo systems. In vitro combined use of SDC/PND. With ACV/GCV rendered tumor cells more sensitive to the prodrugs as compared with the prodrug only in 1 to 20% of TK^+ cells. In the in vivo experiments using nude mice injected with 3 or 10% TK^+ cells, significant reduction in tumor volume was observed in mice treated with drug combinations as compared with those treated with the produg only.4) Toxicity and efficacy: No toxicity of both SDC and PND was seen in mice even at a dose 10-fold higher than that used in the in vivo experiments. SDC has more potent effects than PND, and the possibility for stable supply from organ cultures of the plant.5) Evaluation of the efficiency of liposome vectors: Transfection efficiency of the gene by cationic liposome was increased in the presence of soybean-derived sterylglucoside. The liver targeting was also improved by this liposome.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
K.Hayashi, T.Hayashi: "Recent Development in chemical and Pharmaceutical Sciences"Transworld Research Network(in press). (2002)
K.Hayashi、T.Hayashi:“化学和制药科学的最新发展”Transworld Research Network(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Hayashi, T.Hayashi, H.-D.Sun, Y.takeda: "Potentiation of ganciclovir in herpes simpled virus thymidine kinase/ganciclovir administration system by ponicidin"Cancer Gene Therapy. 7(1). 45-52 (2000)
K.Hayashi、T.Hayashi、H.-D.Sun、Y.takeda:“通过波尼西丁对单纯疱疹病毒胸苷激酶/更昔洛韦给药系统中更昔洛韦的增强作用”癌症基因治疗。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.H.Hwang, K.Hayashi, K.Takayama, Y.Maitani: "Liver-targeted gene taransfer into a human hepatoblastoma cell line and in vivo by steryglueoside-containing cationic liposomes"Gene Therapy. 8(16). 1276-1280 (2001)
S.H.Hwang、K.Hayashi、K.Takayama、Y.Maitani:“通过含有甾醇糖苷的阳离子脂质体将肝脏靶向基因转移到人肝母细胞瘤细胞系中并在体内进行”基因治疗。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K. Hayashi, T. Hayashi, H.-D. Sun, and Y. Takeda: "Contribution of a combination of ponicidin and acyclovir/ganciclovir to the antitumor efficacy in HSV-TK gene therapy system"Human Gene Therapy. 13. 415-423 (2002)
K. Hayashi、T. Hayashi、H.-D。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Hayashi,T.Hayashi,H.D.Sun and Y.Takeda: "Potentiation of ganciclovir in herpes simplex virus thymidine Kinase/ganciclovir administration system by ponicidin"Cancer Gene Therapy. 7巻1号. 45-52 (2000)
K.Hayashi、T.Hayashi、H.D.Sun 和 Y.Takeda:“通过波尼西丁对单纯疱疹病毒胸苷激酶/更昔洛韦给药系统的增强”癌症基因治疗,第 7 卷,第 1. 45-52 期(2000 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 13 条
Characterization of the NS1 mutants induced by a chemical substance
-
批准号:25460206
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2013
-
负责人:HAYASHI Kyoko
-
依托单位:
Attenuatio of influenza virus by drug treatment and elucidation of mechanism of the attenuation
-
批准号:21590153
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:HAYASHI Kyoko
-
依托单位:
Evaluation of anti-human coronavirus agents
-
批准号:16590434
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2004
-
负责人:HAYASHI Kyoko
-
依托单位:
Research on the potentiators of HSV-specific thymidine kinase for the purpose of their application to gene therapy and antiviral therapy
-
批准号:09672276
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1997
-
负责人:HAYASHI Kyoko
-
依托单位:
海外基金